The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, … Continue reading Non Invasive Prenatal Testing (NIPT) Market by Instruments, Application & End User – 2021
biotechnology
The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America
The key players in the glycomics market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.). Factors such as increasing government and private funding for glycomics and proteomics research and … Continue reading The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America
The western blotting market was USD 574.8 Million in 2016, Expect High Growth
Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advansta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.) are some of the key players in the market worldwide. For More Information : http://www.marketsandmarkets.com/pdfdownload.asp?id=235810711 On the … Continue reading The western blotting market was USD 574.8 Million in 2016, Expect High Growth
The biologics safety testing market was valued at USD 2.75 Billion in 2017
The top four players in this market are Lonza Group LTD. (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany) and SGS SA (Switzerland) are. These companies have a broad product & service portfolio with comprehensive features and have a strong geographical presence. By region, the global biologics safety testing market is segmented into North America, … Continue reading The biologics safety testing market was valued at USD 2.75 Billion in 2017
The global high-content screening market estimated USD 557.1 Million in 2017
The major players in the market are GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck … Continue reading The global high-content screening market estimated USD 557.1 Million in 2017
PCR to Dominate the Molecular Diagnostic Technologies Market
The study also provides analytical framework to understand various factors that determine the purchase decision of PCR instruments by end users. These factors include sensitivity, consistent quality of data, high-throughput ability, multiplexing capability, price of instrument, ease of use, services and support, and brand of a system, among others. The purchase decision of PCR instrument … Continue reading PCR to Dominate the Molecular Diagnostic Technologies Market
Polymerase Chain Reaction – Comparative Analysis and End User Preference Study
The overall market for PCR technology market is expected to grow rapidly owing to the expansion of its application areas and increased accuracy and precision. Furthermore, specific technology segments of the PCR market, such as dPCR (real-time PCR) and qPCR (digital PCR), are witnessing higher market growth owing to their benefits such as real-time process … Continue reading Polymerase Chain Reaction – Comparative Analysis and End User Preference Study
There is Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth. … Continue reading There is Increase in Funding for Proteomics and Glycomics Research, Growing R&D Expenditure
New International GMP & GDP Certification for Pharmaceutical Excipients Drive Elemental Analysis Market
The elemental analysis market is expected to reach $6.213 Billion in 2020 from $4.584 Billion in 2015, growing at a CAGR of 6.3%. The market is expected to be dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest rate during the … Continue reading New International GMP & GDP Certification for Pharmaceutical Excipients Drive Elemental Analysis Market
Soft Tissue Repair Market worth $14.7 Billion in 2019
The report “Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World. Browse 70 … Continue reading Soft Tissue Repair Market worth $14.7 Billion in 2019
Healthcare Market Research 